Lakshmi Nayak
- Genetics top 0.1%
- Pulmonary and Respiratory Medicine top 1%
- Oncology top 1%
- Neurology top 0.5%
- Pathology and Forensic Medicine top 1%
- Co-authors
- Patrick Y. WenEudocia Q. LeeFábio M. IwamotoDavid A. ReardonLauren E. AbreyNils D. ArvoldAndrew D. NordenAntonio Omuro
- Topics
- Glioma Diagnosis and Treatment (90 papers)Brain Metastases and Treatment (40 papers)CNS Lymphoma Diagnosis and Treatment (38 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Lakshmi Nayak
119 papers receiving 5.4k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Genetics 2.9k
- Pulmonary and Respiratory Medicine 2.1k
- Oncology 1.8k
- Neurology 1.3k
- Pathology and Forensic Medicine 977
Countries citing papers authored by Lakshmi Nayak
This map shows the geographic impact of Lakshmi Nayak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lakshmi Nayak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lakshmi Nayak more than expected).
Fields of papers citing papers by Lakshmi Nayak
This network shows the impact of papers produced by Lakshmi Nayak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lakshmi Nayak. The network helps show where Lakshmi Nayak may publish in the future.
Co-authorship network of co-authors of Lakshmi Nayak
This figure shows the co-authorship network connecting the top 25 collaborators of Lakshmi Nayak. A scholar is included among the top collaborators of Lakshmi Nayak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lakshmi Nayak. Lakshmi Nayak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 11 | |
| 3 | 6 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 8 | |
| 7 | 6 | |
| 8 | Primary central nervous system lymphomabreakdown → | 77 |
| 9 | 0 | |
| 10 | 160 | |
| 11 | 14 | |
| 12 | Brain metastasesbreakdown → | 668 |
| 13 | 19 | |
| 14 | 35 | |
| 15 | 4 | |
| 16 | 5 | |
| 17 | 99 | |
| 18 | 6 | |
| 19 | 136 | |
| 20 | 49 |
About Lakshmi Nayak
Lakshmi Nayak is a scholar working on Genetics, Neurology and Pathology and Forensic Medicine, having authored 128 papers that have together received 5.5k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (90 papers), Brain Metastases and Treatment (40 papers) and CNS Lymphoma Diagnosis and Treatment (38 papers). The work is most often cited by research in Genetics (2.9k citations), Neurology (1.3k citations) and Oncology (1.8k citations). Lakshmi Nayak has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Patrick Y. Wen, Eudocia Q. Lee, Fábio M. Iwamoto, David A. Reardon, Lauren E. Abrey, Nils D. Arvold, Andrew D. Norden, Antonio Omuro, Riccardo Soffietti and Manmeet S. Ahluwalia. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.